Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study
- CoVIC-DB team
- Center for Infectious Disease and Vaccine Research
- La Jolla Institute for Allergy and Immunology
- Carterra
- Duke University
- Academic Medical Center
- Ltd.
- Ltd.
- Inc.
- Inc
- Inc.
- Inc.
- Twist Bioscience
- Columbia University
- Shanghai Henlius Biotech, Inc.
- Kymab Limited
- Imperial College London
- Celltrion, Inc.
- Boehringer Ingelheim GmbH
- Walter Reed Army Institute of Research
- Fudan University
- AbCipher Biotechnology
- Fred Hutchinson Cancer Research Center
Research output: Contribution to journal › Journal Article › peer-review